ESSA Pharma Inc (EPIX)
1.72
-0.04
(-2.27%)
USD |
NASDAQ |
Nov 15, 16:00
1.73
+0.01
(+0.58%)
After-Hours: 20:00
ESSA Pharma Free Cash Flow (Quarterly): -5.745M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -5.745M |
March 31, 2024 | -6.818M |
December 31, 2023 | -6.787M |
September 30, 2023 | -4.488M |
June 30, 2023 | -4.906M |
March 31, 2023 | -6.011M |
December 31, 2022 | -4.377M |
September 30, 2022 | -7.477M |
June 30, 2022 | -6.317M |
March 31, 2022 | -8.385M |
December 31, 2021 | -5.820M |
September 30, 2021 | -7.383M |
June 30, 2021 | -6.517M |
March 31, 2021 | -7.572M |
December 31, 2020 | -3.943M |
September 30, 2020 | -4.151M |
June 30, 2020 | -3.488M |
March 31, 2020 | -5.984M |
December 31, 2019 | -3.361M |
September 30, 2019 | -5.150M |
June 30, 2019 | -2.494M |
March 31, 2019 | -2.755M |
Date | Value |
---|---|
December 31, 2018 | -1.851M |
September 30, 2018 | -2.234M |
June 30, 2018 | -2.806M |
March 31, 2018 | -3.235M |
December 31, 2017 | -1.943M |
September 30, 2017 | -3.017M |
June 30, 2017 | -5.077M |
March 31, 2017 | -2.708M |
December 31, 2016 | -6.553M |
September 30, 2016 | -3.394M |
June 30, 2016 | -3.391M |
March 31, 2016 | -5.923M |
December 31, 2015 | -2.603M |
September 30, 2015 | -4.844M |
June 30, 2015 | -5.084M |
March 31, 2015 | -1.463M |
December 31, 2014 | -2.122M |
September 30, 2014 | -1.253M |
June 30, 2014 | -0.725M |
March 31, 2014 | 0.0078M |
December 31, 2013 | -0.1113M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.385M
Minimum
Mar 2022
-3.361M
Maximum
Dec 2019
-5.765M
Average
-5.984M
Median
Mar 2020
Free Cash Flow (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 16.90M |
Edesa Biotech Inc | -0.8565M |
Lexaria Bioscience Corp | -1.288M |
Xenon Pharmaceuticals Inc | -34.19M |
ImmunoPrecise Antibodies Ltd | -1.524M |